Wednesday, March 23, 2022 10:38:24 PM
387 / 23 - Blood brain barrier (BBB) disruption by tumor treating fields (TTFields) in a human 3D in vitro model https://www.abstractsonline.com/pp8/#!/10517/presentation/12182
1305 / 15 - Tumor Treating Fields (TTFields) promote a pro-inflammatory phenotype in macrophages https://www.abstractsonline.com/pp8/#!/10517/presentation/16885
1801 / 30 - Application of Tumor Treating Fields (TTFields) to cancer cells enhances their membrane permeability https://www.abstractsonline.com/pp8/#!/10517/presentation/20545
1866 / 11 - Transcriptomics analysis for identification of pathways involved in the response to Tumor Treating Fields (TTFields) https://www.abstractsonline.com/pp8/#!/10517/presentation/16328
2037 / 15 - Spatial omic changes of malignant pleural mesothelioma following treatment using tumor-treating fields https://www.abstractsonline.com/pp8/#!/10517/presentation/12731
2601 / 14 - Concomitant treatment of ovarian cell lines with Tumor Treating Fields (TTFields) and PARP inhibitors https://www.abstractsonline.com/pp8/#!/10517/presentation/12967
2659 / 2 - Inhibition of PI3K sensitized cancer cells to Tumor Treating Fields (TTFields) https://www.abstractsonline.com/pp8/#!/10517/presentation/15079
3156 / 7 - Tumor Treating Fields reduce cellular survival of human mesenchymal stromal cells via apoptosis and senescence induction https://www.abstractsonline.com/pp8/#!/10517/presentation/14670
3252 / 21 - Tumor treating fields suppression of ciliogenesis enhances temozolomide toxicity https://www.abstractsonline.com/pp8/#!/10517/presentation/16105
3447 / 5 - Tumor treating fields (TTFields) treatment planning for a patient with astrocytoma in the spinal cord https://www.abstractsonline.com/pp8/#!/10517/presentation/12120
3450 / 8 - Impact of model inaccuracy on dose estimation in TTFields therapy https://www.abstractsonline.com/pp8/#!/10517/presentation/12124
3465 / 23 - Efficacy of concomitant application of Tumor Treating Fields (TTFields), temozolomide and lomustine in glioblastoma cancer cells in vitro https://www.abstractsonline.com/pp8/#!/10517/presentation/18151
CT234 / 5 - PANOVA-3: A phase 3 study of tumor treating fields with gemcitabine and nab-paclitaxel for front-line treatment of locally advanced pancreatic adenocarcinoma https://www.abstractsonline.com/pp8/#!/10517/presentation/20361
Recent NVCR News
- Novocure to Present Real-World Data at ESMO 2024 Demonstrating Improved Survival Outcomes for Newly Diagnosed Glioblastoma Patients with Increased Use of Tumor Treating Fields (TTFields) Therapy • Business Wire • 09/09/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/03/2024 11:00:17 AM
- Novocure Announces Planned CEO Transition • Business Wire • 09/03/2024 11:00:00 AM
- Novocure to Participate in 2024 Wells Fargo Healthcare Conference • Business Wire • 08/28/2024 11:00:00 AM
- Novocure Highlights TTFields Therapy in Treatment of Non-Small Cell Lung Cancer at 2024 World Conference on Lung Cancer • Business Wire • 08/14/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 08:22:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 08:19:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 08:19:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 08:17:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 08:16:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/05/2024 08:25:19 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 07/25/2024 12:25:38 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/25/2024 11:05:37 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/25/2024 11:01:22 AM
- Novocure Reports Second Quarter 2024 Financial Results • Business Wire • 07/25/2024 11:00:00 AM
- Novocure to Report Second Quarter 2024 Financial Results • Business Wire • 07/01/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/10/2024 08:09:16 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM